Meet the Only AI Stock I'd Buy Over Nvidia in October

ASML reported €3.8 billion in EUV system sales in fiscal Q2 2026, versus €2.8 billion in non-EUV system sales; only one EUV unit sold was High-NA. ASML and Taiwan Semiconductor are targeting a 12-inch photomask pilot line by 2031 and advanced-node manufacturing support by 2033, aiming to expand High-NA efficiency and adoption. The article presents the collaboration and ASML’s EUV position as long-term AI-chip growth drivers, while noting High-NA adoption remains early.

Analysis

The strategic case for ASML is its EUV bottleneck position, not the article’s claim that a 12-inch-mask transition will soon unlock High-NA economics. That program is a 2031 pilot target and a 2033 manufacturing ambition: too distant to support near-term earnings revisions, and exposed to execution, yield, mask-infrastructure and customer-qualification risk. Also, High-NA EUV does not use an 8 nm wavelength; it retains 13.5 nm light and increases numerical aperture. The article’s technical framing overstates the mechanism.

Over the next 1–3 months, watch ASML orders, shipment timing and customer capex commentary rather than treating the collaboration announcement as incremental demand. Over 6–18 months, broader EUV demand may benefit ASML if advanced logic and memory investment holds, while High-NA adoption remains an option, not an established volume driver. TSM could gain wafer productivity if the process works, but also bears implementation costs; SK hynix’s early deployment is not evidence of broad adoption. Intel’s purchase establishes a customer, not successful process economics. AMAT, KLAC and LRCX may participate in fab spending, but the news does not establish that ASML takes share from them.

Contrarian read: the moat is real, but the article bundles that durable position with a long-dated engineering milestone and presents both as one near-term growth catalyst. Without valuation and order-book data, there is no basis to conclude ASML is the best relative-value equipment stock.

Key Decisions for Investors

• Do not chase ASML on the 12-inch-mask announcement alone. Treat it as long-dated optionality; verify customer qualification, pilot-line progress and evidence of improved throughput or cost per wafer before underwriting a High-NA ramp.
• For a 1–3 month catalyst, monitor ASML bookings, EUV shipment schedules and TSM/Intel/SK hynix capex or node-transition updates. A deterioration in orders or delayed customer ramps would falsify the near-term demand thesis.
• If seeking exposure, prefer a staged ASML position on weakness rather than a concentrated event-driven trade; no price target or valuation conclusion is supportable from the supplied information. Reassess against order intake and guidance, not the article’s promotional framing.
• Keep AMAT, KLAC and LRCX as diversified fab-capex comparators rather than automatic shorts: the announcement does not show competitive displacement. A relative-value trade needs valuation, order and end-market mix data first.